18F-FDG PET more accurate than fMRI and may help physicians better determine the long-term recovery of patients with unresponsive wakefulness syndrome.
Cerebral 18F-fluorodeoxyglucose (FDG) PET can assist in predicting the long-term recovery of patients with unresponsive wakefulness syndrome, according to a study published in The Lancet.
Researchers from Belgium, Canada, and Denmark performed a clinical validation study to test the diagnostic accuracy of functional 18F-FDG PET and functional MRI (fMRI) in clinical practice.
The study comprised 41 patients with unresponsive wakefulness syndrome, four with locked-in syndrome, and 81 who were in a minimally conscious state (MCS), diagnosed by the Coma Recovery Scale-Revised (CRS-R). The patients underwent repeated standardized clinical assessments with the CRS-R, 18F-FDG MRI and fMRI during mental activation tasks. Outcome was assessed after 12 months using the Glasgow Outcome Scale-Extended.
The researchers found that overall, the 18F-FDG PET was better than fMRI in distinguishing conscious from unconscious patients. Mental imagery fMRI was less sensitive at diagnoses of a MCS than 18-F FDG PET (45 percent versus 93 percent), and had less agreement with behavioral CRS-R scores than the PET (63 percent versus 85 percent). In addition, the PET was about 74 percent accurate in predicting the extent of recovery within the next year compared with 56 percent with the fMRI.
“Our findings suggest that PET imaging can reveal cognitive processes that aren’t visible through traditional bedside tests, and could substantially complement standard behavioral assessments to identify unresponsive or ‘vegetative’ patients who have the potential for long-term recovery,” lead author Steven Laureys, PhD, of the University of Liege in Belgium, said in a release.
The PET correctly predicted the outcome in 75 of 102 patients (74 percent) and fMRI did so in 36 of 65 patients (56 percent). In addition, 13 of 42 patients who were behaviorally unresponsive showed brain activity compatible with minimal consciousness on at least one neuroimaging test, and nine of 13 (69 percent) subsequently recovered consciousness.
The researchers concluded that cerebral 18F-FDG PET could be used to complement bedside assessments and fMRI may be useful in differential diagnosis but it is not as accurate as the PET.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Large Medicare Study Shows Black Men Less Likely to Receive PET and MRI for Prostate Cancer Imaging
August 3rd 2025An analysis of over 749,000 Medicare beneficiaries diagnosed with prostate cancer over a five-year period found that Black men were 13 percent less likely to receive PET imaging and 16 percent less likely to receive MRI in comparison to White men.
The Reading Room Podcast: Current and Emerging Insights on Abbreviated Breast MRI, Part 3
August 3rd 2025In the last of a three-part podcast episode, Stamatia Destounis, MD, Emily Conant, MD and Habib Rahbar, MD, share additional insights on practical considerations and potential challenges in integrating abbreviated breast MRI into clinical practice, and offer their thoughts on future research directions.
Twenty Years of CT Colonography for Colorectal Cancer Screening: What the Research Reveals
August 3rd 2025Computed tomography colonography (CTC) demonstrated a 91.6 percent positive predictive value (PPV) for polyps > 6 mm, according to new research involving over 9,000 patients who underwent CTC for primary asymptomatic colorectal cancer screening.
The Reading Room Podcast: A Closer Look at Remote MRI Safety, Part 3
August 3rd 2025In the third of a three-part podcast episode, Emanuel Kanal, M.D. and Tobias Gilk, MRSO, MRSE, discuss strategies for maintaining the integrity of time-out procedures and communication with remote MRI scanning.
Chest CT for Post-COVID-19 Abnormalities: Nine Takeaways from a Multi-Society Consensus Statement
August 3rd 2025Developed by 21 thoracic radiologists, the new international consensus statement addresses appropriate indications, scan acquisition and keys to reporting for the use of chest CT imaging in evaluating for residual lung abnormalities from COVID-19.